FDA Drug Recalls

Recalls / Class I

Class ID-1300-2020

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

NP Thyroid 90, Thyroid Tablets, USP, 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-331-01.

Brand name
Np Thyroid 15
Generic name
Levothyroxine, Liothyronine
Active ingredients
Levothyroxine, Liothyronine
Route
Oral
NDCs
42192-327, 42192-329, 42192-330, 42192-331, 42192-328
Affected lot / code info
Lots: M331G18-1 Exp. JUN-2020, M331J18-1, M331J18-2, Exp. AUG-2020, M331M18-1, M331M18-2 Exp. NOV-2020

Why it was recalled

Superpotent Drug.

Recalling firm

Firm
Acella Pharmaceuticals, LLC
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
1880 Mcfarland Pkwy Ste 110-B, N/A, Alpharetta, Georgia 30005

Distribution

Quantity
49,128 bottles
Distribution pattern
Distributed Nationwide in the US and Puerto Rico

Timeline

Recall initiated
2020-05-22
FDA classified
2020-06-08
Posted by FDA
2020-06-10
Terminated
2022-01-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1300-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: Np Thyroid 15 · FDA Drug Recalls